BNP Paribas Financial Markets’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-65,733
Closed -$2.59M 4101
2023
Q2
$2.59M Sell
65,733
-65,868
-50% -$2.32M ﹤0.01% 1611
2023
Q1
$3.2M Buy
131,601
+54,484
+71% +$1.19M ﹤0.01% 1523
2022
Q4
$1.65M Sell
77,117
-59,305
-43% -$1.27M ﹤0.01% 1872
2022
Q3
$2.45M Buy
136,422
+110,786
+432% +$1.45M ﹤0.01% 1828
2022
Q2
$247K Sell
25,636
-92,258
-78% -$1.16M ﹤0.01% 2995
2022
Q1
$1.98M Sell
117,894
-119,532
-50% -$1.77M ﹤0.01% 1818
2021
Q4
$3.97M Buy
237,426
+213,209
+880% +$3.49M 0.01% 1511
2021
Q3
$393K Buy
24,217
+18,019
+291% +$196K ﹤0.01% 2839
2021
Q2
$39.1K Sell
6,198
-27,426
-82% -$177K ﹤0.01% 3352
2021
Q1
$208K Buy
33,624
+22,732
+209% +$138K ﹤0.01% 3029
2020
Q4
$75.3K Sell
10,892
-8,205
-43% -$52.5K ﹤0.01% 3352
2020
Q3
$108K Buy
19,097
+17,406
+1,029% +$83K ﹤0.01% 3077
2020
Q2
$8.62K Buy
1,691
+1,650
+4,024% +$6.88K ﹤0.01% 3766
2020
Q1
$141 Hold
41
﹤0.01% 4202
2019
Q4
$352 Hold
41
﹤0.01% 4273
2019
Q3
$46 Hold
41
﹤0.01% 4467
2019
Q2
$53 Sell
41
-19
-32% -$26 ﹤0.01% 4491
2019
Q1
$85 Hold
60
﹤0.01% 4227
2018
Q4
$72 Hold
60
﹤0.01% 4221
2018
Q3
$142 Hold
60
﹤0.01% 4380
2018
Q2
$164 Hold
60
﹤0.01% 4356
2018
Q1
$164 Hold
60
﹤0.01% 4139
2017
Q4
$187 Hold
60
﹤0.01% 4131
2017
Q3
$169 Hold
60
﹤0.01% 4149
2017
Q2
$154 Sell
60
-519
-90% -$1.41K ﹤0.01% 4168
2017
Q1
$2.12K Sell
579
-551
-49% -$2.33K ﹤0.01% 3529
2016
Q4
$5.46K Sell
1,130
-1,460
-56% -$43.3K ﹤0.01% 3673
2016
Q3
$119K Buy
2,590
+1,382
+114% +$77.9K ﹤0.01% 2013
2016
Q2
$61.6K Buy
1,208
+1,192
+7,450% +$59.2K ﹤0.01% 2258
2016
Q1
$676 Sell
16
-66,894
-100% -$3.41M ﹤0.01% 2539
2015
Q4
$5.25M Sell
66,910
-12,761
-16% -$738K 0.01% 609
2015
Q3
$3.23M Buy
79,671
+46,699
+142% +$2.47M 0.01% 743
2015
Q2
$1.72M Buy
32,972
+32,638
+9,772% +$1.62M ﹤0.01% 929
2015
Q1
$15.5K Buy
+334
New +$17.3K ﹤0.01% 2500
2014
Q4
Sell
-808
Closed -$31.5K 3392
2014
Q3
$31.5K Buy
808
+806
+40,300% +$31.6K ﹤0.01% 2870
2014
Q2
$85 Sell
2
-10
-83% -$367 ﹤0.01% 3763
2014
Q1
$408 Sell
12
-97
-89% -$3.27K ﹤0.01% 3080
2013
Q4
$3.53K Buy
+109
New +$3.23K ﹤0.01% 3319

BNP Paribas Financial Markets's ISEE Position: Q3 2023 in Review

BNP Paribas Financial Markets sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 65,733 shares — an estimated $2.59M sold.

BNP Paribas Financial Markets first reported a position in ISEE in Q4 2013 and held it in 38 quarters. The position peaked at $5.25M in Q4 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • BNP Paribas Financial Markets reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 65,733 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.59M.
  • BNP Paribas Financial Markets first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 38 quarters.
  • BNP Paribas Financial Markets's IVERIC bio, Inc. Common Stock position peaked at $5.25M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2023, filed 14 Nov 2023.